News
Latest News
Contact Us
Study uncovers mechanisms of reactive oxygen species in stem cell function and inflammation prevention
12/12/2022
Findings could improve prevention and treatment of inflammatory bowel diseases Science Daily, October 3, 2022 Mount Sinai researchers have published one of the first studies
From Japan to Duke: Cord Blood for HIE
28/11/2022
Parent’s Guide to Cord Blood, October 2022 Anonymous Parents The following story tells the experiences and impressions of a family that stored umbilical cord blood
The story behind FamiCord becoming the largest cord blood bank in Europe
25/11/2022
Parent’s Guide to Cord Blood, October 2022 Tomasz Baran, MD MBA Cord blood banking in Europe is 25 years old. In 1997, the first family
Stem cell-gene therapy shows promise in ALS safety trial
22/11/2022
Science Daily, September 5, 2022 Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the
ExCellThera Can Improve Patient Access to Cord Blood Transplants
16/11/2022
Parent’s Guide to Cord Blood, September 2022 Frances Verter PhD The pros and cons of cord blood transplants are well-established. The biggest advantage of cord
Muscle models mimic diabetes, inform personalized medicine
16/11/2022
Science Daily, September 13, 2022 Scientists are using in vitro skeletal muscle engineering to gain a better understanding of the complex genetic and environmental factors
Four myths about stem cell banking that new parents should know
16/11/2022
The Indian Express By: Parenting Desk New Delhi | August 24, 2022 Over the past decades, stem cell banking has garnered attention from the general
Experimental umbilical cord stem cell therapy treats rare disease
16/11/2022
NewScientist, 9 June 2022 Clare Wilson A girl with a rare disorder can now breathe more easily after receiving transfusions of a liquid that her
Immune cell model paves way for new treatments targeting common infection amongst immunocompromised children
16/11/2022
Researchers have successfully engineered human immune cells to model an infection common among immunocompromised people in a breakthrough discovery, paving the way for new drug
